Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Repeated childhood stroke and venous thrombosis: the risks

11.06.2007
Being over two-years-old, not being administered anti-coagulant drugs, and having a certain genetic mutation all increase the risks of repeated venous thrombosis (VT) in children, conclude authors of an Article published early Online and in the July edition of The Lancet Neurology.

Professor Ulrike Nowak-Göttl, Department of Paediatric Haematology and Oncology, University Hospital of Münster, Germany, and colleagues did a study of 396 children who had suffered a first cerebral venous thrombosis (CVT/stroke), and monitored them for an average of 36 months to determine the risk of a second cerebral or systemic venous thrombosis. The study is the largest and longest follow-up study of children with a first onset of stroke.

They found that 12 of the children died immediately, while 22 had recurrent VT, of which 13 were cerebral. Recurrent VT only occurred in children over two-years-old, and children who did not receive anti-coagulant drugs were 11 times for likely to have recurrent VT. Children suffering from venous occlusion (blocking of the veins to any blood flow) were over four times more likely to have recurrent VT, as were children with a genetic mutation already known to increase risk of VT.

The authors say: “Although cerebral venous thrombosis is associated with substantial mortality and morbidity, its causes in children have not been extensively investigated.”

Children older than two years who had a second VT did so at an average age of 13 years – the authors propose that this is because after the high risk first year of life, the next highest risk period of a child’s life relating to VT is puberty, probably due to hormonal changes and the down-regulation of the fibrinolytic system. This finding is backed by previous studies.

However the authors caution that continued use of anticoagulants in children has to be balanced against the risks of them suffering haemorrhages due to being physically active, and each case has to be considered individually. Where the risk of repeated VT is high, the benefit of anticoagulant therapy could clearly outweigh the risk of possible haemorrhage.

The authors conclude by calling for larger randomised studies into repeated VTs. They say: “Until data from such studies are available, the message of this follow-up study is clearly that administration of secondary anticoagulation prophylaxis should be considered on an individual patient basis in children with newly identified CVT in situations where the risk of VT is high.”

In an accompanying Comment, Dr Meredith Golomb, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, USA, says: “Recurrent venous thromboembolism after cerebral sinovenous thrombosis can be devastating.”

She then asks: “Which patients absolutely need to be on anticoagulation, and which ones can be safely weaned off? How can we tell the parents of an otherwise healthy five-year-old that he can never sled, perform gymnastics, or wrestle with his siblings? What doses of anticoagulation will keep the risk of recurrence and bleeding to a minimum?”

She concludes: “This paper provides some important answers; however, physicians, patients, and the patients’ families have many more questions.”

Tony Kirby | alfa
Further information:
http://www.thelancet.com

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>